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The TomoTherapy® beam-delivery method creates helical beam-junctioning patterns in the dose 
distribution within the target. In addition, the dose discrepancy results in the particular region 
where the resonance by pattern of dose delivery occurs owing to the change in the position and 
shape of internal organs with a patient's respiration during long treatment times. In this study, we 
evaluated the dose pattern of the longitudinal profile with the change in respiration. The superior-
inferior motion signal of the programmable respiratory motion phantom was obtained using AbChes 
as a four-dimensional computed tomography (4DCT) original moving signal. We delineated virtual 
targets in the phantom and planned to deliver the prescription dose of 300 cGy using field widths 
of 1.0 cm, 2.5 cm, and 5.0 cm. An original moving signal was fitted to reflecting the beam delivery 
time of the TomoTherapy®. The EBT3 film was inserted into the phantom movement cassette, and 
static, without the movement and with the original movement, was measured with signal changes 
of 2.0 s, 4.0 s, and 5.0 s periods, and 2.0 mm and 4.0 mm amplitudes. It was found that a dose 
fluctuation within ±4.0% occurred in all longitudinal profiles. Compared with the original 
movement, the region of the gamma index above 1 partially appeared within the target and the 
border of the target when the period and amplitude were changed. Gamma passing rates were 
95.00% or more. However, cases for a 5.0 s period and 4.0 mm amplitude at a field width of 2.5 
cm and for 2.0 s and 5.0 s periods at a field width of 5.0 cm have gamma passing rates of 92.73%, 
90.31%, 90.31%, and 93.60%. TomoTherapy® shows a small difference in dose distribution 
according to the changes of period and amplitude of respiration. Therefore, to treat a variable 
respiratory motion region, a margin reflecting the degree of change of respiration signal is required. 
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 Introduction
Intensity modulated radiation technique of Tomo­
Therapy® is specified by binary multi­leaf collimator (MLC) 
and simultaneously synchronous motion of gantry rotation 
and couch movement.1) Through this beam delivery 
technique, conformity and homogeneity of target has been 
increased, while the dose of near­by organ at risk (OAR) 
decreased. Therefore, the effectiveness of radiation therapy 
becomes better and more efficient.2) In addition, equipped 
with dynamic jaws in the unit, TomoEDGE®, the region of 
longitudinal penumbra has dramatically been reduced, 
which improves the dosimetric advantages and conformal 
dose distribution as well.3) Owing to helical beam delivery, 
however, the dose distribution in target has junctioning 
patterns and threaded effect. Moreover, compared with 
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volumetric arc therapy (VMAT), treatment time is usually 
longer, which would affect the dose distribution, and 
especially be sensitive to respiratory motion. 
The tumor motion attributed to respiration provides 
the differences between treatment planning and actual 
delivered dose distribution because of its complexity and 
interplay.4­6) Accordingly, target margin would be widely 
applied. The field margin is occasionally considered 
because the difference of dose distribution by the organ 
motion is caused by field width of the TomoTherapy®.7) The 
characteristics of dose distribution can be revised using 
the machine parameters and treatment planning. In the 
other hands, the deformation and reposition of organs 
by respiratory motion would provide dose uncertainty, 
thereby, discrepancy between planned and actual dose. 
Furthermore, the resonance of periodic motions of gantry, 
couch, and respiration would sometimes give a worse 
influence as well. In IMRT beam delivery that consists of 
small sub­fields of beamlets, besides, dose uncertainty 
from respiratory motion could be enhanced. 
In this study, we evaluated the longitudinal dose profile 
attributed to respiratory motion in the treatment using 
TomoTherapy®. 
Materials and Methods
1. Acquisition of respiratory signal and beam 
delivery on moving phantom
For the phantom study, QUASARTM programmable 
respiratory motion phantom (Modus Medical Devices 
Inc. London, Ontario, Canada) was used. 4D CT scan was 
performed with 3 mm­thick slice and respiratory signal 
was programed and transferred to Toshiba CT scanner 
(Toshiba Medical Systems, Otawara, Japan) using the signal 
generated by Abches system (APEX Medical Inc., Tohyo, 
Japan) as shown in Fig. 1. 4D CT scan was reconstructed 
with the 10 phases. In order to obtain the moving images 
and to delineate the target, the wire was inserted within 
the film cassette to indicate targets. Based on the acquired 
CT scan, treatment plan was computed with TomoTherapy 
HTM Series planning station (TomoTherapy Inc., Madison, 
WI, USA). Especially, 4D plan was considered by the 
delineations of two targets on every 10 phases’ CT scans, 
which had cylindrical shapes with the diameter of 3 cm and 
height of 6 cm, which were named by target 1 and 2 (Fig. 
2(a)). The target 2 was just used for the beam modulation, 
Fig. 1. The setup of QUSAR phantom and Abches system for 
acquiring the motion signal.
Fig. 2. (a) Target 1 and Target 2 of 3.0 cm diameter and 6.0 cm 
length in a QUASARTM phantom film cassette and Organs at Risk 
(OARs); (b) EBT3 film inserted in film cassette.
a
b
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and was not for the dose distribution. In addition to the 
delineation of targets, adjacent organ at risk (OAR) was 
contoured as well. Treatment plans was computed with 
field width of 1.0, 2.5, 5.0 cm and every plans with 0.287 
pitch and 2 modulation factor. Prescribed dose was 3.0 Gy 
on both targets with 10 fractions. 
Generally, the TomoTherapy® takes a long time than the 
computed tomography (CT) simulation. To consider the 
real treatment environment, instead of programed signal, 
we were applied the surrogation obtained from AbChes, 
which were re­processed using Matlab version R2010a (The 
MathWorks Inc., Natick, MA) to cover the time range of 
treatment with the same respiratory period and fitted by up 
to 7th order of Gaussian function as follows:
)ωcos(7tb)ωsin(7ta)ωcos(6tb)ωsin(6ta         
...)ωsin(2tb)ωcos(2ta)ωsin(tb)ωcos(taaf(t)
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    (1)
where coefficients, a0­a7 and b1­b7 can be determined by 
fitting, t and w mean the time and angular frequency.
2. Measurement and analysis of the profile along 
longitudinal direction
The EBT3 film was inserted into film cassette of QUASARTM 
phantom described in Fig. 2(b). The measurement were 
made with the condition of “static” which represents no 
respiratory motion and “dynamic” which consists of 6 
different conditions: phantom original movement acquired 
from CT simulation, movement changed of 3 respiratory 
periods (2.0, 4.0, 5.0 second) and 2 amplitudes (2.0, 4.0 
mm). Moreover, we applied 3 different field width (1.0, 
2.5, 5.0 cm) where 3 different monitor units (MU), 5198 
MU, 2703 MU, and 1898 MU were delivered respectively. 
Measured films were analyzed by RIT113 ver. 6.3 software 
(@2014, USA) with constant region of interest (ROI), 3 
cm×3 cm square. The longitudinal profiles by dynamic 
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Fig. 3. The longitudinal profile according to change of phase and 
amplitude at the center axis (a) 1.0 cm field width; (b) 2.5 cm 
field width; (c) 5.0 cm field width.
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conditions were compared with the static condition. And 
then, to evaluate the effects of dose distributions according 
to the change of motion signal, the original movement 
and modified movement were compared by using gamma 
passing rate and gamma index. The gamma passing rate 
with the criteria of 3.0%/3.0 mm and gamma index were 
analyzed. The gamma index above 1 means that there 
were 3.0% or more dose differences between both dose 
distributions. 
Results
1. Longitudinal profile of QUASAR phantom
The residual sum of square (R­square) was obtained from 
the respiratory curve fitted by equition1. The R­square was 
0.992 as goodness of fit that the fitting curve was similar to 
the original curve. Compared with static, the longitudinal 
profiles of dynamic movements were measured with 
a little dose fluctuation less than 4% within target 1. In 
Fig. 3, longitudinal profile crossing a center of target is 
shown, where, (−) and (+) mean the superior and inferior 
direction of phantom, respectively. When the amplitude 
was changed, the variation of profiled along central axis 
was compared with static case. That had been found up to 
3.04%, −3.77% and −3.97% in the target border area corres­
ponding to 1.0, 2.5, and 5.0 cm field widths, respectively. In 
addition, two profiles measured with different amplitudes 
showed the percentage differences of up to −2.02%, −4.00% 
and −3.31% for the jaw field sizes of 1.0, 2.5, and 5.0 cm, 
respectively. 
Dose difference (X, −X) in the longitudinal profile of 
regions, where were shifted 1.5 cm left and right from 
center of the target, showed the values of up to (3.07%, 
−4.05%),  (−3.71%, −4.02%) and (−3.97%, −2.02%), 
respectively (Fig. 4, 5). 
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Fig. 4. The longitudinal profile according to change of phase and 
amplitude at the region shifted left 1.5 cm from center axis (a) 1.0 
cm field width; (b) 2.5 cm field width; (c) 5.0 cm field width.
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2. Gamma passing rates on target area with 
respiratory motions 
Table 1 shows the gamma passing rates for the target 
region when the signal is changed compared to the original 
phantom movement. Gamma passing rates almost have 
95.00% or more. However, cases for 5.0 s period and 4.0 
mm amplitude at 2.5 cm field width represent the gamma 
passing rate of 92.73% and 90.31%, cases for 2.0 s and 5.0 
s period at 5.0 cm in field width have 90.31% and 93.60% 
respectively. Fig. 6 shows the 2D gamma index map with 
5.0 s period and 4.0 mm amplitude which have the greatest 
change in period and amplitude. When the period changes, 
the regions with gamma index above 1 appear (red) within 
the target. At the time of amplitude change, the area of 
gamma index 1 or more appears at the border of the target 
region except for the case of 4.0 mm amplitude on the 2.5 
cm field width. 
Discussion and Conclusion
TomoTherapy® improves the conformity and homo­
geneity within the target through continuous movement 
of couch, gantry and MLC. It also reduces the dose to 
adjacent OARs. 
In addition, accurate positioning and setup of the patient 
is possible using MVCT. However, since TomoTherapy® 
Table 1. Gamma passing rates within the target for each period 
and amplitude according to field width compared with original 
movement.
Field width
1.0 cm 2.5 cm 5.0 cm
2.0 s Period 95.50% 97.87% 90.31%
4.0 s Period 97.79% 96.11% 97.08%
5.0 s Period 95.52% 92.73% 93.60%
2.0 mm Amplitude 97.92% 97.10% 98.71%
4.0 mm Amplitude 96.15% 90.31% 95.21%
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Fig. 5. The longitudinal profile according to change of phase and 
amplitude at the region shifted right 1.5 cm from center axis (a) 1.0 
cm field width; (b) 2.5 cm field width; (c) 5.0 cm field width.
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has not control system which is possible to considering 
the respiration of patients such as gating radiotherapy, it 
is necessary to consider the margin of target or the system 
for respiration control such as Deep­inspiration Breath 
Hold (DIBH). In this study, we assessed the dose effect of 
TomoTherapy® on the longitudinal direction of the target 
when different respiratory periods or phases were applied 
to the original respiration according to each field width. 
The period of 2.0 s, 4.0 s, 5.0 s and amplitude of 2.0 mm 
and 4.0 mm were changed in the original respiratory, 
respectively. Analysis results of the measured EBT3 film 
showed that non­uniform profile was formed regardless of 
the field width when the same respiration signal was given. 
This is because the narrow slit beam of TomoTherapy® 
crosses the target of the patient. M.W. Kissick et al.8) have 
proposed a factor of 0.86 to reduce the thread effect of the 
"ripple" (peak to trough relative to the average) and helical 
beam junctioning patterns occurring in the beam­axis 
profile. However, this factor is reflected in TomoTherapy® 
planning system. In actual treatment, patient's respiratory 
pattern can act as a modulation factor in dose distribution. 
However, from the results of gamma passing rates of 
more than 95.0%, there is no significant difference in dose 
distribution, even though there may be dose fluctuations 
in one axis of the longitudinal direction by change in 
respiration relative to the original respiratory signal. When 
the motion was changed by 2.0 s period applied to the 2.5 
cm field width, the dose difference of longitudinal profile 
of the center axis within the target is assumed to be a 
random error in the gamma passing rate range of 97.87% 
(Fig. 2(a), Table 1). It was confirmed that the gamma index 
in the target showed a value of 1 or more when the period 
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was changed. The reason is considered to be a regional 
resonance phenomenon that can occur when the target 
motion frequency and the helical beam frequency coincide 
with each other. When the amplitudes were changed, it 
was confirmed that 1 or more gamma index were mainly 
shown in the border region of the target except one or more 
gamma index in the target of 2.5 cm field width. However, 
it is difficult to identify a uniform pattern through this 
study. Because the change of respiration was selectively 
variated, the dose distribution around the target was not 
analyzed due to the size limitation of the film cassette in 
the phantom. In addition, phantom motion was restricted 
to the superior­inferior direction and did not show 
anterior­posterior and left­right changes. Study showed 
that changes in the original respiratory motion signal do 
not significantly affect overall dose delivery. However, even 
though TomoTherapy® plan defines target and movement 
in 10 phases of respiration, changes in respiratory period 
and amplitude can make areas under or over dose in target 
area. 
Therefore, in order to treat a variable­motion region 
using TomoTherapy®, a target margin reflecting the 
degree of change of periode and amplitude from original 
respiratory signal may be considered for the accurate 
radiation treatment. 
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